Neurogene Inc. (NASDAQ:NGNE) Financings

Neurogene Inc.

Financings

RaiseDate
Public offering of shares
Closed: US$144M raised
Aug 11, 2026
Public offering of shares of common stock and pre-funded warrants
Update: about US$125M · US$30 a share · Leerink Partners +4
Dealers: Leerink Partners (co-lead), Stifel (co-lead), Guggenheim Securities (co-lead), LifeSci Capital (co-lead), William Blair (co-lead)
Use of proceeds: Fund clinical development and pre-commercial activities for NGN-401, working capital and general corporate purposes
Jul 1, 2026

Read by 6ix AI from the company's releases